Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Obsessive Compulsive Disorder in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* DSM-IV Diagnosis of obsessive compulsive disorder~* CYBOCS total score greater than 16~Exclusion Criteria:~* Other primary or co-primary psychiatric disorder~* Pervasive developmental disorder or disorders, including Asperger's Syndrome~* Thought disorder~* Prior failed trial of cognitive-behavioral therapy~* Has pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) or maintenance antibiotic for obsessive-compulsive disorder~* Mental retardation~* Pregnancy

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- MedMgmt+CBT (Type: EXPERIMENTAL): Participants will receive the following interventions: 1)SRI medication management with a psychiatrist plus, 2) cognitive behavioral therapy with a psychologist.
- MedMgmt+I-CBT (Type: EXPERIMENTAL): Participants will receive the following interventions 1)SRI medication management plus, 2) instructional cognitive behavioral therapy. Both of these will be implemented by the same psychiatrist.
- MedMgmt Only (Type: ACTIVE_COMPARATOR): Participants will receive the intervention SRI medication management with a psychiatrist

Based on this trial design, predict the completion outcome and termination type (if applicable).